Ferredoxin-NADP Reductase

"Ferredoxin-NADP Reductase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An enzyme that catalyzes the oxidation and reduction of FERREDOXIN or ADRENODOXIN in the presence of NADP. EC 1.18.1.2 was formerly listed as EC 1.6.7.1 and EC 1.6.99.4.

Descriptor ID

D005287

MeSH Number(s)

D08.811.682.667.076

Concept/Terms

Ferredoxin-NADP Reductase

Below are MeSH descriptors whose meaning is more general than "Ferredoxin-NADP Reductase".

Chemicals and Drugs [D]
Enzymes and Coenzymes [D08]
Enzymes [D08.811]
Oxidoreductases [D08.811.682]
Oxidoreductases Acting on Sulfur Group Donors [D08.811.682.667]
Ferredoxin-NADP Reductase [D08.811.682.667.076]

Below are MeSH descriptors whose meaning is related to "Ferredoxin-NADP Reductase".

Below are MeSH descriptors whose meaning is more specific than "Ferredoxin-NADP Reductase".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Ferredoxin-NADP Reductase" by people in Harvard Catalyst Profiles by year, and whether "Ferredoxin-NADP Reductase" was a major or minor topic of these publication.

Bar chart showing 9 publications over 7 distinct years, with a maximum of 3 publications in 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2006	1	0	1
2007	2	1	3
2011	0	1	1
2013	1	0	1
2015	1	0	1
2016	1	0	1
2020	0	1	1

Below are the most recent publications written about "Ferredoxin-NADP Reductase" by people in Profiles.

Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Res Treat. 2020 Jun; 181(3):623-633.

View in: PubMed
Associations of homocysteine status and homocysteine metabolism enzyme polymorphisms with hypertension and dyslipidemia in a Chinese hypertensive population. Clin Exp Hypertens. 2020; 42(1):52-60.

View in: PubMed
Characteristic peripheral blood smear findings in disorders of cobalamin metabolism. Blood. 2016 11 24; 128(21):2584.

View in: PubMed
Network Analysis Identifies Mitochondrial Regulation of Epidermal Differentiation by MPZL3 and FDXR. Dev Cell. 2015 Nov 23; 35(4):444-57.

View in: PubMed
Folate-mediated one-carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: Women's Health Initiative Observational Study. Cancer. 2015 Oct 15; 121(20):3684-91.

View in: PubMed
Gene polymorphisms as risk factors for predicting the cardiovascular manifestations in Marfan syndrome. Role of folic acid metabolism enzyme gene polymorphisms in Marfan syndrome. Thromb Haemost. 2015 Oct; 114(4):748-56.

View in: PubMed
What's the Mtrr with your grandparents? Cell Metab. 2013 Oct 01; 18(4):457-9.

View in: PubMed
Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia. Schizophr Bull. 2013 Mar; 39(2):330-8.

View in: PubMed
Crystal structure of a ferredoxin reductase for the CYP199A2 system from Rhodopseudomonas palustris. Proteins. 2009 Dec; 77(4):867-80.

View in: PubMed
Genetic variation in homocysteine metabolism, cognition, and white matter lesions. Neurobiol Aging. 2010 Nov; 31(11):2020-2.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

Proteins
Microbiology (Reading)
J Rheumatol
J Microbiol Biotechnol
Dev Cell
Clin Exp Hypertens
Cell Metab
Blood
Biochim Biophys Acta
Biochem Biophys Res Commun